These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Erythrocyte-UFA (Eufa) mobility test for multiple sclerosis: implications for pathogenesis and handling of the disease. Field EJ; Joyce G; Smith BM J Neurol; 1977 Jan; 214(2):113-27. PubMed ID: 64595 [TBL] [Abstract][Full Text] [Related]
3. Red-cell-membrane differences in multiple sclerosis are acquired from plasma. Seaman GV; Swank RL; Zukoski CF Lancet; 1979 May; 1(8126):1139. PubMed ID: 86857 [No Abstract] [Full Text] [Related]
4. Screening of children at risk of multiple sclerosis. Forrester JA; Smith WJ Lancet; 1977 Aug; 2(8035):453-4. PubMed ID: 70661 [No Abstract] [Full Text] [Related]
5. Screening of children at risk of multiple sclerosis. Field EJ; Joyce G Lancet; 1977 Jul; 2(8029):141. PubMed ID: 69222 [No Abstract] [Full Text] [Related]
7. Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update. O'Connor PW; Kremenchutzky M Can J Neurol Sci; 2015 Nov; 42(6):372-80. PubMed ID: 26503087 [No Abstract] [Full Text] [Related]
8. Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis. Ciccarelli O; Thompson A Nat Rev Neurol; 2016 Feb; 12(2):70-2. PubMed ID: 26823149 [No Abstract] [Full Text] [Related]